Sabri, Osama

Percutaneous Coronary Angioplasty Compared With Exercise Training in Patients With Stable Coronary Artery Disease: A Randomized Trial

Hambrecht, R., Walther, C., Möbius-Winkler, S., Gielen, S., Linke, A., Conradi, K., Erbs, S., Kluge, R., Kendziorra, K., Sabri, O., et al. (2004) · Circulation

Coronary Interventions and DiagnosticsCardiovascular and exercise physiology

Cited by 752

Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study

Sabri, O., Sabbagh, M. N., Seibyl, J., Barthel, H., Akatsu, H., Ouchi, Y., Senda, K., Murayama, S., Ishii, K., Takao, M., et al. (2015) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 602

JuSpace : A tool for spatial correlation analyses of magnetic resonance imaging data with nuclear imaging derived neurotransmitter maps

Dukart, J., Holiga, S., Rullmann, M., Lanzenberger, R., Hawkins, P. C. T., Mehta, M. A., Hesse, S., Barthel, H., Sabri, O., Jech, R., et al. (2021) · Human Brain Mapping

Functional Brain Connectivity StudiesAdvanced MRI Techniques and Applications

Cited by 347

Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum

Jansen, W. J., Janssen, O., Tijms, B. M., Vos, S. J. B., Ossenkoppele, R., Visser, P. J., Amyloid Biomarker Study Group, Aarsland, D., Alcolea, D., Altomare, D., et al. (2022) · JAMA Neurology

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 290

New Reference Intervals for Thyrotropin and Thyroid Hormones Based on National Academy of Clinical Biochemistry Criteria and Regular Ultrasonography of the Thyroid

Kratzsch, J., Fiedler, G. M., Leichtle, A., Brügel, M., Buchbinder, S., Otto, L., Sabri, O., Matthes, G., & Thiery, J. (2005) · Clinical Chemistry

Thyroid Disorders and TreatmentsClinical Laboratory Practices and Quality Control

Cited by 235

Maternal immune activation results in complex microglial transcriptome signature in the adult offspring that is reversed by minocycline treatment

Mattei, D., Ivanov, A., Ferrai, C., Jordan, P., Guneykaya, D., Buonfiglioli, A., Schaafsma, W., Przanowski, P., Deuther-Conrad, W., Brust, P., et al. (2017) · Translational Psychiatry

Neuroinflammation and Neurodegeneration MechanismsTryptophan and brain disorders

Cited by 222

qPET – a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma

Hasenclever, D., Kurch, L., Mauz-Körholz, C., Elsner, A., Georgi, T., Wallace, H., Landman-Parker, J., Moryl-Bujakowska, A., Cepelová, M., Karlén, J., et al. (2014) · European Journal of Nuclear Medicine and Molecular Imaging

Lymphoma Diagnosis and TreatmentMedical Imaging Techniques and Applications

Cited by 157

Serotonin and dopamine transporter imaging in patients with obsessive-compulsive disorder

Hesse, S., Müller, U., Lincke, T., Barthel, H., Villmann, T., Angermeyer, M. C., Sabri, O., & Stengler-Wenzke, K. (2005) · Psychiatry Research: Neuroimaging

Obsessive-Compulsive Spectrum DisordersNeurotransmitter Receptor Influence on Behavior

Cited by 155

Test–retest measurements of dopamine D1-type receptors using simultaneous PET/MRI imaging

Kaller, S., Rullmann, M., Patt, M., Becker, G.-A., Luthardt, J., Girbardt, J., Meyer, P. M., Werner, P., Barthel, H., Bresch, A., et al. (2017) · European Journal of Nuclear Medicine and Molecular Imaging

Neurotransmitter Receptor Influence on BehaviorMedical Imaging Techniques and Applications

Cited by 152

Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies

Dukart, J., Mueller, K., Horstmann, A., Vogt, B., Frisch, S., Barthel, H., Becker, G., Möller, H. E., Villringer, A., Sabri, O., et al. (2010) · NeuroImage

Dementia and Cognitive Impairment ResearchMedical Imaging Techniques and Applications

Cited by 134

Evaluation of early-phase [18F]-florbetaben PET acquisition in clinical routine cases

Daerr, S., Brendel, M., Zach, C., Mille, E., Schilling, D., Zacherl, M. J., Bürger, K., Danek, A., Pogarell, O., Schildan, A., et al. (2017) · NeuroImage: Clinical

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 124

PET/MR in Dementia and Other Neurodegenerative Diseases

Barthel, H., Schroeter, M. L., Hoffmann, K.-T., & Sabri, O. (2015) · Seminars in Nuclear Medicine

Dementia and Cognitive Impairment ResearchMedical Imaging Techniques and Applications

Cited by 123

Serum neurofilament light chain in behavioral variant frontotemporal dementia

Steinacker, P., Anderl-Straub, S., Diehl-Schmid, J., Semler, E., Uttner, I., von Arnim, C. A. F., Barthel, H., Danek, A., Fassbender, K., Fliessbach, K., et al. (2018) · Neurology

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 116

Comparison of 18F‐florbetaben quantification results using the standard Centiloid, MR‐based, and MR‐less CapAIBL® approaches: Validation against histopathology

Doré, V., Bullich, S., Rowe, C. C., Bourgeat, P., Konate, S., Sabri, O., Stephens, A. W., Barthel, H., Fripp, J., Masters, C. L., et al. (2019) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 93

Early detection of amyloid load using 18F-florbetaben PET

Bullich, S., Roé-Vellvé, N., Marquié, M., Landau, S. M., Barthel, H., Villemagne, V. L., Sanabria, Á., Tartari, J. P., Sotolongo-Grau, O., Doré, V., et al. (2021) · Alzheimer's Research & Therapy

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 71

Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin’s Lymphoma

Kluge, R., Chavdarova, L., Hoffmann, M., Kobe, C., Malkowski, B., Montravers, F., Kurch, L., Georgi, T., Dietlein, M., Wallace, W. H., et al. (2016) · PLOS ONE

Lymphoma Diagnosis and TreatmentReliability and Agreement in Measurement

Cited by 56

Adult attention-deficit/hyperactivity disorder is associated with reduced norepinephrine transporter availability in right attention networks: a (S,S)-O-[11C]methylreboxetine positron emission tomography study

Ulke, C., Rullmann, M., Huang, J., Luthardt, J., Becker, G.-A., Patt, M., Meyer, P. M., Tiepolt, S., Hesse, S., Sabri, O., et al. (2019) · Translational Psychiatry

Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on Behavior

Cited by 43

Individual regional associations between Aβ-, tau- and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathies

Finze, A., Biechele, G., Rauchmann, B.-S., Franzmeier, N., Palleis, C., Katzdobler, S., Weidinger, E., Guersel, S., Schuster, S., Harris, S., et al. (2023) · Molecular Psychiatry

Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments

Cited by 40

Serotonin transporter gene promoter methylation status correlates with in vivo prefrontal 5-HTT availability and reward function in human obesity

Drabe, M., Rullmann, M., Luthardt, J., Boettcher, Y., Regenthal, R., Ploetz, T., Becker, G. A., Patt, M., Schinke, C., Bergh, F. T., et al. (2017) · Translational Psychiatry

Neurotransmitter Receptor Influence on BehaviorEpigenetics and DNA Methylation

Cited by 32

Multicenter 18F-PI-2620 PET for In Vivo Braak Staging of Tau Pathology in Alzheimer’s Disease

Rullmann, M., Brendel, M., Schroeter, M. L., Saur, D., Levin, J., Perneczky, R. G., Tiepolt, S., Patt, M., Mueller, A., Villemagne, V. L., et al. (2022) · Biomolecules

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 29

Autoradiography of 2‐[18F]F‐A‐85380 on nicotinic acetylcholine receptors in the porcine brain in vitro

Deuther‐Conrad, W., Wevers, A., Becker, G., Schildan, A., Patt, M., Sabri, O., Steinbach, J., & Brust, P. (2006) · Synapse

Nicotinic Acetylcholine Receptors StudyRadiopharmaceutical Chemistry and Applications

Cited by 12

Technical note: A PET/MR coil with an integrated, orbiting 511 keV transmission source for PET/MR imaging validated in an animal study

Renner, A., Rausch, I., Cal Gonzalez, J., Laistler, E., Moser, E., Jochimsen, T., Sattler, T., Sabri, O., Beyer, T., Figl, M., et al. (2022) · Medical Physics

Medical Imaging Techniques and ApplicationsAdvanced MRI Techniques and Applications

Cited by 3